Healthpeak Properties (DOC) recently completed an IPO of its senior housing business in March 2026, a move that reshapes its healthcare focused real estate portfolio and gives investors a fresh lens on the stock.
Healthpeak Properties’ recent restructuring sits against a share price of US$21.03, with a 90 day share price return of 7.3% and a year to date share price return of 29.8%. Total shareholder return is 26.8% over one year but has declined 23.5% over five years, suggesting momentum has picked up recently even as longer term holders have had a tougher run.
Spot opportunities across healthcare focused real estate by scanning our hand picked list of solid balance sheet and fundamentals (52 results) alongside Healthpeak Properties after this latest restructuring move.Healthpeak Properties trades at a discount to both analyst targets and an estimated intrinsic value after the senior housing IPO reshaped its mix. Is that a sensible cushion for risk, or has the market become overly cautious on the stock?
Most Popular Narrative: 1.9% Undervalued
Healthpeak Properties has a narrative fair value of $21.44 against a last close of $21.03, which points to only a small implied discount and a finely balanced outlook.
Ongoing, multi-year demographic tailwinds from an aging U.S. population are increasing demand for senior housing and independent living facilities (like Healthpeak's CCRC portfolio). This is supporting higher occupancy and growing entrance fees, which directly contribute to revenue and operating earnings growth.
Want to see what really underpins that fair value for Healthpeak Properties? The narrative leans on measured revenue growth, slimmer margins, and a punchy profit multiple. Curious which exact assumptions have to hold for that to stack up? The full breakdown shows how those moving parts fit together.
Result: Fair Value of $21.44 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, investors still need to weigh the risk that weaker biotech tenants in Healthpeak Properties lab segment or prolonged capital market stress could pressure occupancy, refinancing costs and earnings.
Find out about the key risks to this Healthpeak Properties narrative.
Next Steps
Sentiment around Healthpeak Properties is mixed, so use this moment to move quickly and check the key facts for yourself. To balance the concerns against the potential upside, review the 2 key rewards and 4 important warning signs.
Looking for more investment ideas beyond Healthpeak Properties?
If you stop here, you risk missing other opportunities that could fit your goals just as well as Healthpeak Properties, or even better, so keep going.
- Target resilient balance sheets by checking the list of solid balance sheet and fundamentals (52 results) that highlights companies with stronger fundamentals alongside Healthpeak Properties.
- Hunt for potential value opportunities by reviewing the 54 high quality undervalued stocks that surfaces stocks with quality metrics at prices that may look appealing.
- Strengthen your income focus by scanning the 11 dividend fortresses that highlights companies offering higher yields with an emphasis on durability.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com